Andrew Bomback is a Nephrology physician affiliated with Columbia University Irving Medical Center. OpenAlex indexes 336 publications with 12,921 citations (h-index 57). By OpenAlex citation count, this profile ranks in the top 10% of Nephrology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
622 W 168th St
Ph 4-124
New York, NY 100323720
Telephone
212-305-0320Registry record last updated 24 Aug 2011.
Industry payments
19 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Otsuka Pharmaceutical Development & Commercialization, Inc.Program year20258 payments$12,827openpaymentsdata.cms.gov ↗
- Apellis Pharmaceuticals, Inc.Program year20252 payments
- GlaxoSmithKline, LLC.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
69.2%SGLT2 inhibitor49%Farxiga53%Jardiance47%Part D<11 patientsVitamin D3 Analog20.2%Calcitriol100%Part D<11 patientsCardiovascular
30.8%Aldosterone antagonist (MRA)18.3%Eplerenone100%Part D<11 patientsStatin12.5%Atorvastatin Calcium100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
4 NIH research awards on record, funded 2014–2026 per NIH RePORTER. The latest:
- The Columbia PCC for CureGN: the Cure Glomerulonephropathy network
Columbia University Health Sciences
FY2026$953,161U01DK100876 - The Columbia PCC for CureGN: the Cure Glomerulonephropathy network
Columbia University Health Sciences
FY2026$86,485U01DK100876 - The Columbia PCC for CureGN: the Cure Glomerulonephropathy network
Columbia University Health Sciences
FY2026$42,204U01DK100876
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Stanley Fahn, MD
Columbia University Irving Medical Center
Rebecca Hahn, MD
Columbia University Irving Medical Center
Susheel Kodali, MD
Columbia University Irving Medical Center
Ronald Wapner, MD
Columbia University Irving Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”